ArticleClinical ophthalmology (Auckland, N.Z.)2026
Early Visual Performance and Subjective Experience After Bilateral Implantation of a Novel Fully Refractive Extended Depth of Focus Intraocular Lens.
Article in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To outline the early postoperative visual performance and subjective quality of vision (QoV) after implantation of a new fully refractive extended depth of focus intraocular lens (IOL). Patients and Methods: The study enrolled 103 patients undergoing bilateral phacoemulsification with implantation of the Tecnis PureSee IOL (Johnson & Johnson). Refraction, uncorrected (UDVA) and best-corrected (CDVA) distance visual acuities, uncorrected intermediate (UIVA) and near (UNVA) visual acuities, defocus curves, electronic reading desk, QoV questionnaire and a halo and glare simulator were evaluated 3 months postoperatively. Results: Mean binocular UDVA, UIVA and UNVA were -0.06 ± 0.07, 0.05 ± 0.08 and 0.20 ± 0.08 logMAR respectively. At 3 months, 83% were within ± 0.50D and 99% within ± 1.00D of the refractive aim. Minimal dysphotopsias and overall QoV scores of 8.68 ± 1.13 for the day and 8.08 ± 1.58 at night were reported. Of all patients, 98.1% reported better vision than preoperatively and 86.4% would recommend the procedure. Spectacle independence for distance, intermediate, and near was achieved in 100%, 94.2% and 66% of patients respectively. Conclusion: The Tecnis PureSee IOL provided excellent distance and intermediate vision with good functional near vision. Patients reported high postoperative QoV and subjective functional vision, with minimal visual side effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.